CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma.
about
Hepatoepigenetic Alterations in Viral and Nonviral-Induced Hepatocellular Carcinoma.EZH2-mediated suppression of lncRNA-LET promotes cell apoptosis and inhibits the proliferation of post-burn skin fibroblasts.Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signalingIncreased expression of claudin-17 promotes a malignant phenotype in hepatocyte via Tyk2/Stat3 signaling and is associated with poor prognosis in patients with hepatocellular carcinomaTiHo-0906: a new feline mammary cancer cell line with molecular, morphological, and immunocytological characteristics of epithelial to mesenchymal transition
P2860
CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
CLDN14 is epigenetically silen ...... r in hepatocellular carcinoma.
@en
type
label
CLDN14 is epigenetically silen ...... r in hepatocellular carcinoma.
@en
prefLabel
CLDN14 is epigenetically silen ...... r in hepatocellular carcinoma.
@en
P2093
P2860
P50
P356
P1433
P1476
CLDN14 is epigenetically silen ...... er in hepatocellular carcinoma
@en
P2093
Chang-Peng Li
Feng-Wei Wang
Jie-Wei Chen
Li-Juan Jiang
Mu-Yan Cai
Shi-Juan Mai
Wen-Hui Chen
Xiao-Han Jin
Xiao-Qing Pei
P2860
P304
P356
10.1093/CARCIN/BGW036
P407
P577
2016-03-31T00:00:00Z